Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Continuous Intrathecal TPA Infusion for IVH Clearance With Ventricular Irrigation

NCT07643493 is registered in ClinicalTrials.gov with David Dornbos as lead sponsor.

NCT NCT07643493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07643493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Continuous Intrathecal TPA Infusion for IVH Clearance With Ventricular Irrigation
Lead sponsor
David Dornbos
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
July 31, 2026
Completion date
May 31, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraventricular brain hemorrhage, tissue plasminogen activator